ASH 2022 | sciencenewsnet.in

Breaking News

Vaccine shows promise against aggressive breast cancer

Researchers Reveal Why a Key Tuberculosis Drug Works Against Resistant Strains

New study links air pollution with increased risk of spontaneous preterm births

Linking data on genetics, traits and environment gives crop breeders a wider lens

Exposure to Marijuana in the Womb May Increase Risk of Addiction to Opioids Later in Life, Study Finds

NYC’s ride-hailing fee failed to ease Manhattan traffic, new NYU Tandon study reveals

Treatment advances, predictive biomarkers stand to improve bladder cancer care

NJ Becomes First State to Have Statewide Law Enforcement & Mental Health Alternative Response Program in Nation

Cedars-Sinai Experts Available for Interviews During American College of Rheumatology Convergence 2024

University of Central Florida’s A Team with A Dream secures gold at the DOE’s 10th CyberForce Competition®

14 Nov, 2024

Novel Drug Shows Early Promise in Treating Multiple Myeloma

December 11, 2022 sarah JonasResearch Results

A first-of-its-kind drug known as modakafusp alfa has shown early potential in combating multiple myeloma, a form of bone marrow cancer, in a study presented by researchers from the University of Pennsylvania’s Abramson Cancer Center at the 2022 American Society of Hematology (ASH) Annual Meeting (Abstract 565).